Halozyme Therapeutics Inc (NAS:HALO)
$ 48.2 -0.27 (-0.56%) Market Cap: 6.13 Bil Enterprise Value: 6.97 Bil PE Ratio: 15.96 PB Ratio: 13.54 GF Score: 90/100

Halozyme Therapeutics Inc (HALO) Transcripts

  • 1